There were 2,375 press releases posted in the last 24 hours and 359,581 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Innovation Pharmaceuticals Completes Gastric Fluid Testing of Brilacidin Supporting Development of an Oral Dosage Form to Treat Inflammatory Bowel Disease

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image